Send someone a link to this article. They'll recieve an email with a your name, a link to the article and an optional message.

NYSSA The New York State Society of Anesthesiologists, Inc.

Back to "In This Issue"

Volume 78 Number 1

Remimazolam at Westchester Medical Center: Early Adoption, Safety Insights, and Applications

As the case volume of non-operating room anesthesia (NORA) continues to grow, anesthesiologists must balance patient safety, efficiency and the unique organizational challenges within NORA procedural environments. Remimazolam, an ultra-short-acting benzodiazepine, is a new drug that may be safely used in non-OR settings.

You'll have to be logged in to keep reading.

NYSSA Supporter
MLMIC Insurance Company
Endorsed Vendors
Charles J. Sellers & Co MLMIC Insurance Company Weiss Zarett Brofman Sonnenklar & Levy, P.C.

Website design, development and hosting by MAjor Designs